4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4 Lenvatinib Mesylate Intermediate Purity >98,0% (HPLC)
Pasokan Kimia Ruifu Lenvatinib Mesylate Intermediates Kanthi Kemurnian Dhuwur
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Metil 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Metil 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimetil-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Jeneng Kimia | 4-Amino-3-Klorofenol Hidroklorida |
sinonim | 2-Chloro-4-Hydroxyaniline Hydrochloride |
Nomer CAS | 618-89-3 |
Nomer CAT | RF-PI1969 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C6H6ClNO·HCl |
Bobot Molekul | 180.03 |
Titik Lebur | 254,0 ~ 256,0 ℃ (des.) (lit.) |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Brown Solid Powder |
Kemurnian / Metode Analisis | > 98,0% (HPLC) |
Kemurnian / Metode Analisis | 97,5~102,5% (Titrasi kanthi AgNO3) |
Mundhut ing Pangatusan | <0,50% |
Sisa ing Ignition | <0,30% |
Total Impurities | <2.00% |
Spektrum Infra Merah | Conforms kanggo Struktur |
Proton NMR Spectrum | Conforms kanggo Struktur |
Test Standar | Standar Perusahaan |
Panggunaan | Penengah saka Lenvatinib Mesylate (CAS: 857890-39-2) |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
4-Amino-3-Chlorophenol Hydrochloride (CAS: 52671-64-4) minangka perantara saka Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib (jeneng dagang Lenvima) minangka obat anti-kanker kanggo perawatan jinis kanker tiroid tartamtu, lan uga duweni potensi kanggo kanker liyane.Lenvatinib digunakake kanggo ngobati kanker tiroid sing beda-beda sing sacara lokal berulang utawa metastatik, progresif, lan ora nanggapi perawatan karo yodium radioaktif (radioiodine).Iki digunakake kanggo nambani kanker tiroid lan kanker ginjel.Bandingake inhibitor kinase.Lenvatinib minangka inhibitor multi-target saka VEGFR2 lan VEGFR3 kanthi IC50 saka 4 nM lan 5.2 nM, masing-masing.